Phase 2Recruiting
Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty
A Multicenter, Randomized, Open-label, Positive-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of H001 Capsules in the Prevention of Venous Thromboembolism (VTE) in Subjects Undergoing Total Knee Arthroplasty
- Sponsor
- Livzon Pharmaceutical Group Inc. (Industry)
- Enrollment
- 320 planned
- Conditions
- Circulatory Disease
- Interventions
- H001 Capsule 200mg-qd; Enoxaparin Sodium Injection; H001 Capsule 300mg-qd; H001 Capsule 200mg-bid
- Ages
- adults, older adults
- Registry
- NCT06963320
Full record on ClinicalTrials.gov
From the registry
This study is a multicenter, randomized, open-label, positive-controlled Phase II clinical study to evaluate the efficacy and safety of H001 capsules in the prevention of venous thromboembolism (VTE) in subjects undergoing Total Knee Arthroplasty.
Primary outcomes
- Incidence of total VTE
History
Study completion
Primary completion
Registered
Started